Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.4200 (2.14%) ($12.4200 - $12.6750) on Wed. May. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.67% (three month average) | RSI | 54 | Latest Price | $12.4200(2.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(36%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.835% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) IGOV(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.835% (StdDev 5.67%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.53(-0.88%) | 10 Day Moving Average | $11.93(4.11%) | 20 Day Moving Average | $11.88(4.55%) | To recent high | -8.9% | To recent low | 30.8% | Market Cap | $2.191b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |